Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析

◆英語タイトル:Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15323
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Australian Pharmaceutical Industries Ltd (API) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Australian Pharmaceutical Industries Ltd (API) is an integrated healthcare service provider. The company produces, retails, markets and sells health and beauty care products. It markets these products under various brand names such as Priceline & Priceline Pharmacy, Soul Pattinson Chemist, Pharmacist Advice, Club Premium and Pharmacy Best Buys. API procures various health, beauty, and lifestyle products and sells them on retail basis. It also manufactures pharmaceutical products; and owns rights of medicines and consumer toiletries in New Zealand. The company also offers pharmacy services, professional care services and counselling for various patients related to specific medication needs. API is headquartered in Camberwell, Victoria, Australia.

Australian Pharmaceutical Industries Ltd Key Recent Developments

Oct 18,2018: Australian Pharmaceutical Industries: 2018 Full year results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Australian Pharmaceutical Industries Ltd – Key Facts
Australian Pharmaceutical Industries Ltd – Key Employees
Australian Pharmaceutical Industries Ltd – Key Employee Biographies
Australian Pharmaceutical Industries Ltd – Major Products and Services
Australian Pharmaceutical Industries Ltd – History
Australian Pharmaceutical Industries Ltd – Company Statement
Australian Pharmaceutical Industries Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Australian Pharmaceutical Industries Ltd – Business Description
Geographical Segment: Australia
Performance
Overview
Geographical Segment: New Zealand
Performance
Overview
Australian Pharmaceutical Industries Ltd – SWOT Analysis
SWOT Analysis – Overview
Australian Pharmaceutical Industries Ltd – Strengths
Australian Pharmaceutical Industries Ltd – Weaknesses
Australian Pharmaceutical Industries Ltd – Opportunities
Australian Pharmaceutical Industries Ltd – Threats
Australian Pharmaceutical Industries Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Australian Pharmaceutical Industries Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Oct 18, 2018: Australian Pharmaceutical Industries: 2018 Full year results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Australian Pharmaceutical Industries Ltd, Key Facts
Australian Pharmaceutical Industries Ltd, Key Employees
Australian Pharmaceutical Industries Ltd, Key Employee Biographies
Australian Pharmaceutical Industries Ltd, Major Products and Services
Australian Pharmaceutical Industries Ltd, History
Australian Pharmaceutical Industries Ltd, Other Locations
Australian Pharmaceutical Industries Ltd, Subsidiaries
Australian Pharmaceutical Industries Ltd, Key Competitors
Australian Pharmaceutical Industries Ltd, Ratios based on current share price
Australian Pharmaceutical Industries Ltd, Annual Ratios
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Australian Pharmaceutical Industries Ltd, Interim Ratios
Australian Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Australian Pharmaceutical Industries Ltd, Performance Chart (2014 - 2018)
Australian Pharmaceutical Industries Ltd, Ratio Charts

★海外企業調査レポート[Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merafe Resources Ltd:企業の戦略・SWOT・財務分析
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Range Resources Corp (RRC):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • SGL Carbon SE:企業の戦略・SWOT・財務分析
    SGL Carbon SE - Strategy, SWOT and Corporate Finance Report Summary SGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ShotSpotter Inc (SSTI):企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dubai Islamic Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • iDD biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary iDD biotech SAS (iDD biotech) is a healthcare products provider that discovers and develops differentiated therapeutic antibodies. The company's products comprise pre-clinical stage therapeutic monoclonal antibodies and active drug discovery programs. It develops therapies for the treatment …
  • CG Power and Industrial Solutions Ltd (CGPOWER):企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Newalta Corp (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • Columbus McKinnon Corp (CMCO):企業の財務・戦略的SWOT分析
    Summary Columbus McKinnon Corp (CMCO) is an industrial equipment company that offers cranes and hoists. The company designs, manufactures and markets material handling systems and services, which are used for moving, lifting, positioning and securing materials. Its products include hoists, actuators …
  • Sibur Holding:企業の戦略的SWOT分析
    Sibur Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gulf Resources Inc (GURE):企業の財務・戦略的SWOT分析
    Gulf Resources Inc (GURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fujifilm Holdings Corporation (FUJIY):製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Holdings Corp (Fujifilm) sales and manufactures imaging systems and document solution equipment. The company’s major products are color films, color paper and chemicals, photofinishing equipment, electronic imaging and optical devices, TV camera lenses, security lenses, healthcare p …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆